Rypdal, K. B., Erusappan, P. M., Melleby, A. O., Seifert, D. E., Palmero, S., Strand, M. E., . . . Lunde, I. G. (2021). The extracellular matrix glycoprotein ADAMTSL2 is increased in heart failure and inhibits TGFβ signalling in cardiac fibroblasts. Nature Portfolio.
Style de citation Chicago (17e éd.)Rypdal, Karoline B., et al. The Extracellular Matrix Glycoprotein ADAMTSL2 Is Increased in Heart Failure and Inhibits TGFβ Signalling in Cardiac Fibroblasts. Nature Portfolio, 2021.
Style de citation MLA (8e éd.)Rypdal, Karoline B., et al. The Extracellular Matrix Glycoprotein ADAMTSL2 Is Increased in Heart Failure and Inhibits TGFβ Signalling in Cardiac Fibroblasts. Nature Portfolio, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.